Neil Sanghavi

Current Position

Title: President & Head of Solutions Company: Atropos Health Location: Columbus, Ohio Metropolitan Area (primary); New York City (company headquarters)

Professional Background

Neil Sanghavi is an accomplished healthcare executive and entrepreneur with deep expertise in healthcare analytics, real-world evidence, provider strategy, and healthcare technology commercialization. His career reflects a progression from strategic planning and analytics roles at large healthcare institutions to leadership positions at venture-backed health technology startups and major healthcare initiatives.

Starting his career with strategic roles at Cleveland Clinic and The Advisory Board Company (acquired by Optum), Sanghavi moved into product and commercial leadership at healthcare startups Centivo and Aver, demonstrating versatility across organizational scale. He then led provider analytics and strategy for Haven, the high-profile joint venture formed by Amazon, JPMorgan Chase, and Berkshire Hathaway, where he owned critical provider-facing analytics and strategic initiatives. In 2020, Sanghavi began his journey with Atropos Health on a part-time basis focusing on product and launch strategy before becoming President in 2021, where he now oversees go-to-market and product strategy for the company's real-world evidence platform.

Beyond his primary role at Atropos, Sanghavi has served as an advisor to multiple health technology companies including Turquoise Health, Abridge, Tuva Health, and Ribbon Health, focusing on go-to-market strategy, data architecture, and commercial development. He has also been involved with LinkMD.ai, a revenue cycle management AI platform, in a leadership capacity. His academic and clinical advisory work positions him as an informed voice on publication-grade evidence and real-world data methodologies in healthcare.

Career Timeline

Education

• B.S. in Health Care Strategy, The Ohio State University (2010)
• M.S. in Applied Economics, Johns Hopkins University (2013)

Public Presence

Social Media

Note: Only publicly accessible profiles are documented.

Published Writings

• "Lessons from Neil Sanghavi, President and Head of Product and Solutions at Atropos on developing publication-grade evidence for healthcare and life sciences" — Pear Healthcare Playbook (October 2024)
• "Developing Publication-Grade Evidence for Healthcare and Life Sciences" — Atropos Health blog (2024)
• Various posts and articles on LinkedIn discussing healthcare analytics, real-world evidence, and AI applications in healthcare

Public Speaking

• Speaker at HLTH conference (2024) — healthcare industry leadership summit
• Featured in "Pear Healthcare Playbook" podcast episode (October 8, 2024) discussing publication-grade evidence, ChatRWD, data quality, and healthcare innovation

Communication Style

Tone: Conversational yet precise; accessible to clinical and business audiences without sacrificing technical accuracy. Recurring themes: Real-world evidence as a critical gap-filler between expert opinion and RCTs; pragmatic product development; data quality and fitness scoring; democratizing clinical evidence; AI-driven solutions for evidence generation. Notable positions: Strong advocate for observational research as essential to clinical decision-making; champion of rapid evidence generation (days vs. months); emphasizes practical value of real-world data in bedside clinical decision-making.

Sanghavi's communication style reflects a pragmatist's approach to healthcare innovation. In his Pear Healthcare Playbook appearance, he articulated a nuanced philosophy about evidence hierarchies in medicine, arguing that "there must be something in the middle" between expert opinion and gold-standard RCTs—positioning real-world data as that essential middle ground. His discussion of Atropos's "fitness scoring" methodology demonstrates comfort explaining complex analytics concepts to mixed audiences, using concrete examples (oncology drug comparisons, phenotype definitions) to ground abstract concepts.

His approach to product development is pragmatic rather than revolutionary. Rather than building entirely new solutions, he describes leveraging existing institutional assets strategically—exemplified by ChatRWD, which repurposed thousands of completed studies through language models. This reflects a philosophy of maximizing existing value before pursuing novel directions. His communication acknowledges practical constraints and real-world complexity while maintaining focus on measurable outcomes and clinical utility.

Notable Achievements

• Led development of ChatRWD, Atropos Health's AI-driven platform that reduces publication-grade real-world evidence generation from months to minutes
• Oversaw expansion of Atropos Evidence Network to 300+ million patient records across federated health systems
• Contributed to Atropos Health's Series A funding success and positioning as industry leader in real-world evidence
• Recognized as part of Atropos Health team's inclusion in Time's Best Inventions (2025)
• Led provider analytics and strategy initiatives at Haven during critical joint venture period (Amazon, JPMorgan, Berkshire Hathaway partnership)
• Established Atropos Health's go-to-market strategy and product roadmap as company scaled from startup to operational maturity

Key Relationships

• Co-founder and leadership colleague at Atropos Health
• Advisor to health technology companies: Turquoise Health, Abridge, Tuva Health, Ribbon Health
• Healthcare industry network spanning Cleveland Clinic, The Advisory Board Company, Haven, and major healthcare systems
• Collaborator with Mayo Clinic on real-world evidence initiatives
• Academic and clinical connections through Johns Hopkins University background
• Leadership involvement with LinkMD.ai (agentic AI for revenue cycle management)